Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+202.0%
5Y CAGR+42.9%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
+202.0%/yr
vs -7.9%/yr prior
5Y CAGR
+42.9%/yr
Recent acceleration
Acceleration
+209.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6x
Strong expansion
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
20240.19+170.0%
20230.07+835.6%
20220.01+9.0%
20210.01-39.3%
20200.01-64.3%
20190.03+542.2%
20180.00-48.2%
20170.01-
20160.00-
20150.00-